Endurant Iis
Device Aortic Stent Grafts
PDI 00643169439979
General payments
$6,002,980
Research payments
$4,226,431
Through program year 2025, $6,002,980 in general payments and $4,226,431 in research payments were reported against Endurant Iis (Aortic Stent Grafts).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,174,224 | 8,865 |
| 2025 | Research | $1,694,830 | 411 |
| 2024 | General | $1,585,617 | 10,080 |
| 2024 | Research | $1,112,252 | 303 |
| 2023 | General | $1,553,914 | 10,895 |
| 2023 | Research | $987,387 | 227 |
| 2022 | General | $1,688,902 | 8,418 |
| 2022 | Research | $431,962 | 109 |
| 2021 | General | $323 | 14 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 80 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
38,272 general · 1,050 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.